ELX-02 treatment improved podocyte foot process effacement in all three patients by an average of 60% based on a blinded kidney biopsy analysis by NIPOKA GmbH Biopsy results support clinical benefit ...
WATERTOWN, Mass., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported results from an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results